Multiple-Dose Activated Charcoal: A Review of Relevant Clinical Studies

References

• Arimori K., Nakano M. Accelerated clearance of intravenously administered theophylline and phenobarbital by oral doses of activated charcoal in rats. A possibility of the intestinal dialysis. J Pharm‐acobiodyn 1986; 9: 437–441
   PubMedGoogle Scholar
• Neuvonen P. J., Elonen E. Effect of activated charcoal on absorption and elimination of phenobarbitone, carbamazepineand phenylbutazone in man. Eur J Clin Pharmacol 1980; 17: 51–57
   PubMed Web of Science ®Google Scholar
• Berg M. J., Berlinger W. G., Goldberg M. J., Spector R., Johnson G. F. Acceleration of the body clearance of phenobarbital by oral activated charcoal. N Engl J Med 1982; 307: 642–644
   PubMed Web of Science ®Google Scholar
• Berg M. J., Rose J. Q., Worster D. E., Rahman S., Fincham R. W., Schottelius D. D. Effect of charcoal and sorbitol‐charcoal suspension on the elimination of intravenous phenobarbital. Ther Drug Monit 1987; 9: 41–47
   PubMed Web of Science ®Google Scholar
• Goldberg M. J., Berlinger W. G. Treatment of phenobarbital overdose with activated charcoal. JAMA 1982; 247: 2400–2401
   PubMed Web of Science ®Google Scholar
• Pond S. M., Olson K. R., Osterloh J. D., Tong T. G. Randomized study of the treatment of phenobarbital overdose with repeated doses of activated charcoal. JAMA 1984; 251: 3104–3108
   PubMed Web of Science ®Google Scholar
• Goldberg M. J., Berlinger W. G., Park G. D. Activated charcoal in phenobarbital overdose. JAMA 1985; 253: 1120–1121
   PubMed Web of Science ®Google Scholar
• Pond S. M., Osterloh J. D., Olson K. R., Tong T. G. Activated charcoal in phenobarbital overdose. JAMA 1985; 253: 1121
   PubMed Web of Science ®Google Scholar
• Boldy D. A. R., Vale J. A., Prescott L. F. Treatment of phenobarbitone poisoning with repeated oral administration of activated charcoal. Q J Med 1986; 61: 997–1002
   PubMedGoogle Scholar
• Veerman M., Espejo M. G., Christopher M. A., Knight M. Use of activated charcoal to reduce elevated serum phenobarbital concentration in a neonate. J Toxicol Clin Toxicol 1991; 29: 53–58
   PubMed Web of Science ®Google Scholar
• Mofenson H. C., Caraccio T. R., Greensher J., D'Agostino R., Rossi A. Gastrointestinal dialysis with activated charcoal and cathartic in the treatment of adolescent intoxications. Clin Pediatr 1985; 24: 678–684
   PubMed Web of Science ®Google Scholar
• Inotsume N., Kimoto A., Katsuya H., Nakano M., Higashi A. Accelerated elimination of phenobarbital by oral activated charcoal suspensions with alkaline diuresis in an overdose patient. Jpn J Clin Pharmacol Ther 1988; 19: 779–781
   Google Scholar
• Amitai Y., Degani Y. Treatment of phenobarbital poisoning with multiple dose activated charcoal in an infant. J Emerg Med 1990; 8: 449–450
   PubMedGoogle Scholar
• Benet L. Z., Williams R. L. Table A‐II‐1. The Pharmacological Basis of Therapeutics8th Ed., A. G. Gilman, T. W. Rail, A. S. Nies, P. Taylor. Pergamon Press, New York 1990; 1699
   Google Scholar
• Jacobsen D., Wiik‐Larsen E., Dahl T., Enger E., Lunde P. K. Pharmacokinetic evaluation of haemoperfusion in phenobarbital poisoning. Eur J Clin Pharmacol 1984; 26: 109–112
   PubMed Web of Science ®Google Scholar
• Berman L. B., Jeghers H. J., Schreiner G. E., Pallotta A. J. Hemodialysis, an effective therapy for acute barbiturate poisoning. JAMA 1956; 161: 820–827
   PubMed Web of Science ®Google Scholar
• Vale J. A. The Medical Management of Acute Poisoning. An Evaluation of Charcoal Haemoperfusion MD Thesis, University of London, London 1980
   Google Scholar
• Boldy D. A., Heath A., Ruddock S., Vale J. A., Prescott L. F. Activated charcoal for carbamazepine poisoning. Lancet 1987; 1: 1027
   PubMed Web of Science ®Google Scholar
• Hundt H. K. L., Aucamp A. K., Moller F. O. Pharmacokinetic aspects of carbamazepine and its two major metabolites in plasma during overdosage. Hum Toxicol 1983; 2: 607–614
   PubMedGoogle Scholar
• Vree T. B., Janssen T. J., Hekster Y. A., Termond E. F., Van de Dries A. C., Wijnands W. J. Clinical pharmacokinetics of carbamazepine and its epoxy and hydroxy metabolites in humans after an overdose. Ther Drug Monitor 1986; 8: 297–304
   PubMed Web of Science ®Google Scholar
• Wason S., Baker R. C., Carolan P., Seigel R., Drucken‐brod R. W. Carbamazepine overdose ‐ the effects of multiple dose activated charcoal. J Toxicol Clin Toxicol 1992; 30: 39–48
   PubMed Web of Science ®Google Scholar
• Vale J. A., Heath A. Carbamazepine overdose. J Toxicol Clin Toxicol 1992; 30: 481–482
   PubMed Web of Science ®Google Scholar
• Nilsson C., Sterner G., Idvall J. Charcoal hemoperfusion for treatment of serious carbamazepine poisoning. Acta Med Scand 1984; 216: 137–140
   PubMed Web of Science ®Google Scholar
• De Groot G., Van Heijst A. N. P., Maes R. A. A. Charcoal hemoperfusion in the treatment of two cases of acute carbamazepine poisoning. J Toxicol Clin Toxicol 1984; 22: 349–362
   PubMed Web of Science ®Google Scholar
• Leslie P. J., Heyworth R., Prescott L. F. Cardiac complications of carbamazepine intoxication: treatment by haemoperfusion. Br Med J 1983; 286: 1018
   PubMed Web of Science ®Google Scholar
• Kulig K. W., Bar‐Or D., Rumack B. H. Intravenous theophylline poisoning and multiple‐dose charcoal in an animal model. Ann Emerg Med 1987; 16: 842–846
   PubMed Web of Science ®Google Scholar
• Chyka P. A., Mandrell T. D., Holley J. E., Sugathan P. Evaluation of a porcine model to study repeat‐dose activated charcoal therapy. Vet Hum Toxicol 1993; 35: 367
   Google Scholar
• Berlinger W. G., Spector R., Goldberg M. J., Johnson G. F., Quee C. K., Berg M. J. Enhancement of theophylline clearance by oral activated charcoal. Clin Pharmacol Ther 1983; 33: 351–354
   PubMed Web of Science ®Google Scholar
• Mahutte C. K., True R. J., Michiels T. M., Berman J. M., Light R. W. Increased serum theophylline clearance with orally administered activated charcoal. Am Rev RespirDis 1983; 128: 820–822
   PubMed Web of Science ®Google Scholar
• Park G. D., Radomski L., Goldberg M. J., Spector R., Johnson G. F., Quee C. K. Effects of size and frequency of oral doses of charcoal on theophylline clearance. Oin Pharmacol Ther 1983; 34: 663–666
   Web of Science ®Google Scholar
• Radomski L., Park G. D., Goldberg M. J., Spector R., Johnson G. F., Quee C. K. Model for theophylline overdose treatment with oral activated charcoal. Clin Pharmacol Ther 1984; 35: 402–408
   PubMed Web of Science ®Google Scholar
• Ilkhanipour K., Yealy D. M., Krenzelok E. P. The comparative efficacy of various multiple‐dose activated charcoal regimens. Am J Emerg Med 1992; 10: 298–300
   PubMed Web of Science ®Google Scholar
• Lim D. T., Singh P., Nourtsis S., Dela‐Cruz R. Absorption inhibition and enhancement of elimination of sustained‐release theophylline tablets by oral activated charcoal. Ann Emerg Med 1986; 15: 1303–1307
   PubMed Web of Science ®Google Scholar
• Goldberg M. J., Spector R., Park G. D., Johnson G. F., Roberts P. The effect of sorbitol and activated charcoal on serum theophylline concentrations after slow‐release theophylline. Clin Pharmacol Ther 1987; 41: 108–111
   PubMed Web of Science ®Google Scholar
• True R. J., Berman J. M., Mahutte C. K. Treatment of theophylline toxicity with oral activated charcoal. Crit Care Med 1984; 12: 113–114
   PubMed Web of Science ®Google Scholar
• Gal P., Miller A., McCue J. D. Oral activated charcoal to enhance theophylline elimination in an acute overdose. JAMA 1984; 251: 3130–3131
   PubMed Web of Science ®Google Scholar
• Sesser C. N., Glauser F. L., Cooper K. R. Treatment of theophylline toxicity with oral activated charcoal. Chest 1985; 87: 325–329
   PubMed Web of Science ®Google Scholar
• Ohning B. L., Reed M. D., Blumer J. L. Continuous nasogastric administration of activated charcoal for the treatment of theophylline intoxication. Pediatr Pharmacol 1986; 5: 241–245
   PubMedGoogle Scholar
• Bronstein A. C., Sawyer D. R., Rumack B. H., Black E. M. Theophylline intoxication in a premature infant‐multiple dose activated charcoal therapy. Vet Hum Toxicol 1984; 26: 47S
   Google Scholar
• Davis R., Ellsworth A., Justus R. E., Bauer L. A. Reversal of theophylline toxicity using oral activated charcoal. J Fam Pract 1985; 20: 73–74
   PubMed Web of Science ®Google Scholar
• Amitai Y., Yeung A. C., Moye J., Lovejoy F. H. Repetitive oral activated charcoal and control of emesis in severe theophylline toxicity. Ann Intern Med 1986; 105: 386–387
   PubMed Web of Science ®Google Scholar
• Shannon M., Amitai Y., Lovejoy F. H. Multiple dose activated charcoal for theophylline poisoning in young infants. Pediatrics 1987; 80: 368–370
   PubMed Web of Science ®Google Scholar
• Lee C. S., Peterson J. C., Marbury T. C. Comparative pharmacokinetics of theophylline in peritoneal dialysis and haemodialysis. J Clin Pharmacol 1983; 23: 274–280
   PubMed Web of Science ®Google Scholar
• Lee C. S., Marbury T. C., Perrin J. H., Fuller T. J. Haemodialysis of theophylline in uremic patients. J Oin Pharmacol 1979; 19: 219–226
   Google Scholar
• Woo O. F., Pond S. M., Benowitz N. L., Olson K. R. Benefit of hemoperfusion in acute theophylline intoxication. J Toxicol Clin Toxicol 1984; 22: 411–424
   PubMed Web of Science ®Google Scholar
• Connell J. M. C., McGeachie J. F., Knepil J., Thomson A., Junor B. Self‐poisoning with sustained‐release aminophylline; secondary rise in serum theophylline concentration after charcoal haemoperfusion. Br Med J 1982; 284: 943
   PubMed Web of Science ®Google Scholar
• Wogan J. M., Kulig K., Frommer D. A. Multiple‐dose activated charcoal in salicylate poisoning. Ann Emerg Med 1986; 15: 651
   Google Scholar
• Barone J. A., Raia J. J., Huang Y. C. Evaluation of the effects of multiple‐dose activated charcoal on the absorption of orally administered salicylate in a simulated toxic ingestion model. Ann Emerg Med 1988; 17: 34–37
   PubMed Web of Science ®Google Scholar
• Kirshenbaum L. A., Mathews S. C., Sitar D. S., Tenenbein M. Does multiple‐dose charcoal therapy enhance salicylate excretion?. Arch Intern Med 1990; 150: 1281–1283
   PubMed Web of Science ®Google Scholar
• Ho J. L., Tierney M. G., Dickinson G. E. An evaluation of the effect of repeated doses of oral activated charcoal on salicylate elimination. J Clin Pharmacol 1989; 29: 366–369
   PubMed Web of Science ®Google Scholar
• Mayer A. L., Sitar D. S., Tenenbein M. Multiple‐dose charcoal and whole‐bowel irrigation do not increase clearance of absorbed salicylate. Arch Intern Med 1992; 152: 393–396
   PubMed Web of Science ®Google Scholar
• Vale J. A. Methods to increase poison elimination. New Clinical Applications: Nephrology. Drugs and the Kidney, G. R. D. Catto. Kluwer Academic, Lancaster 1990; 65–111
   Google Scholar
• Hillman R. J., Prescott L. F. Treatment of salicylate poisoning with repeated oral charcoal. Br Med J 1985; 291: 1472
   PubMed Web of Science ®Google Scholar
• Vertrees J. E., McWilliams B. C., Kelly H. W. Repeated oral administration of activated charcoal for treating aspirin overdose in young children. Pediatrics 1990; 85: 594–598
   PubMed Web of Science ®Google Scholar
• Prescott L. F., Balali‐Mood M., Critchley J. A., Johnstone A. F., Proudfoot A. T. Diuresis or urinary alkalinization for salicylate poisoning?. Br Med J Clin Res Ed 1982; 285: 1383–1386
   PubMed Web of Science ®Google Scholar
• Lockey D., Bateman D. N. Effect of oral activated charcoal on quinine elimination. Br J Clin Pharmacol 1989; 27: 92–94
   PubMed Web of Science ®Google Scholar
• Prescott L. F., Hamilton A. R., Heyworth R. Treatment of quinine overdosage with repeated oral charcoal. Br J Oin Pharmacol 1989; 27: 95–97
   Web of Science ®Google Scholar
• Bateman D. N., Blain P. G., Woodhouse K. W., et al. Pharmacokinetics and clinical toxicity of quinine overdosage: lack of efficacy of techniques intended to enhance elimination. Q J Med 1985; 54: 125–131
   PubMedGoogle Scholar
• Neuvonen P. J., Elonen E., Mattila M. J. Oral activated charcoal and dapsone elimination. Clin Pharmcol Ther 1980; 27: 823–827
   PubMed Web of Science ®Google Scholar
• Neuvonen P. J., Elonen E., Haapanen E. J. Acute dapsone intoxication: clinical findings and effect of oral charcoal and haemodialysis on dapsone elimination. Acta Med Scand 1983; 214: 215–220
   PubMed Web of Science ®Google Scholar
• Watson W. A., Cremer K. F., Chapman J. A. Gastrointestinal obstruction associated with multiple‐dose activated charcoal. J Emerg Med 1986; 4: 401–407
   PubMedGoogle Scholar
• Ray M. J., Radin D. R., Condie J. D., Halls J. M. Charcoal bezoar. Small‐bowel obstruction secondary to amitriptyline overdose therapy. Dig Dis Sci 1988; 33: 106–107
   PubMed Web of Science ®Google Scholar
• Atkinson S. W., Young Y., Trotter G. A. Treatment with activated charcoal complicated by gastrointestinal obstruction requiring surgery. Br Med J 1992; 305: 563
   PubMed Web of Science ®Google Scholar
• Mizutani T., Naito H., Oohashi N. Rectal ulcer with massive haemorrhage due to activated charcoal treatment in oral organophosphate poisoning. Hum Exp Toxicol 1991; 10: 385–386
   PubMed Web of Science ®Google Scholar
• Benson B., Van Antwerp M., Hergott T. A fatality resulting from multiple dose activated charcoal therapy. Vet Hum Toxicol 1989; 31: 335
   Google Scholar
• Goulbourne K. B., Cisek J. E. Small‐bowel obstruction secondary to activated charcoal and adhesions. Ann Emerg Med 1994; 24: 108–110
   PubMed Web of Science ®Google Scholar
• Harsch H. H. Aspiration of activated charcoal. N Engl J Med 1986; 314: 318
   PubMed Web of Science ®Google Scholar
• Menzies D. G., Busuttil A., Prescott L. F. Fatal pulmonary aspiration of oral activated charcoal. Br Med J 1988; 297: 459–460
   PubMed Web of Science ®Google Scholar
• Rau N. R., Nagaraj M. V., Prakash P. S., Nelli P. Fatal pulmonary aspiration of oral activated charcoal. Br Med J 1988; 297: 918–919
   Web of Science ®Google Scholar